Literature DB >> 9256475

Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

S Hirose1, K Yan, M Abe, Y Jiang, Y Hamano, H Tsurui, T Shirai.   

Abstract

The Fas/Fas ligand (FasL) system participates in regulation of the immune system through the apoptotic process. However, the extent to which abnormalities in this system are involved in the loss of self-tolerance and development of autoimmune disease not associated with Fas/FasL mutations remains unknown. The present study addresses this issue in Fas/FasL-intact, systemic lupus erythematosus (SLE)-prone (NZB x NZW) (NZB/W) F1 mice. While splenic B cells from 2-month-old mice before overt SLE expressed Fas poorly, in vitro stimulation with an agonistic anti-CD40 mAb up-regulated their Fas expression, thus revealing the existence of two populations: one was Fashigh and highly susceptible to anti-Fas mAb-induced apoptosis, and the other was Faslow and apoptosis-resistant. The Faslow cells were included in the CD5(+) B cell subpopulation and contained most of the cells that produced IgM anti-DNA antibodies. The isotype of anti-DNA antibodies switches from IgM to IgG in NZB/W F1 mice at ages beginning at about 6 months. These IgG anti-DNA antibodies were produced almost exclusively by a subpopulation of splenic B cells that spontaneously expressed low levels of Fas in vivo and were apoptosis-resistant. The findings indicate that precursor B cells for autoantibody production and presumably autoantibody-secreting cells in these mice are relatively resistant to Fas-mediated apoptosis, a finding supporting the concept that abnormalities of Fas-mediated apoptotic process are involved in the development of autoreactive B cells in Fas/FasL-intact autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256475      PMCID: PMC23161          DOI: 10.1073/pnas.94.17.9291

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways.

Authors:  C Kocks; K Rajewsky
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens.

Authors:  S B Hartley; J Crosbie; R Brink; A B Kantor; A Basten; C C Goodnow
Journal:  Nature       Date:  1991-10-24       Impact factor: 49.962

3.  Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations.

Authors:  L Linton PJ; D J Decker; N R Klinman
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

Review 4.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

5.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

6.  Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.

Authors:  I Sekigawa; T Okada; K Noguchi; G Ueda; S Hirose; H Sato; T Shirai
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras.

Authors:  D L Perkins; R M Glaser; C A Mahon; J Michaelson; A Marshak-Rothstein
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

8.  Tolerance-related V beta clonal deletions in normal CD4-8-, TCR-alpha/beta + and abnormal lpr and gld cell populations.

Authors:  P A Singer; R S Balderas; R J McEvilly; M Bobardt; A N Theofilopoulos
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

9.  Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2- T cells of lpr mice.

Authors:  B L Kotzin; S K Babcock; L R Herron
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  4 in total

1.  Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis.

Authors:  S Kodama; M Suzuki; M Arita; G Mogi
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.

Authors:  Kiminori Kimura; Hisataka Moriwaki; Masahito Nagaki; Masanao Saio; Yasunari Nakamoto; Makoto Naito; Kazuo Kuwata; Francis V Chisari
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Increased expression of CD154 and FAS in SLE patients' lymphocytes.

Authors:  Maria Elena Manea; Ruediger B Mueller; Doru Dejica; Ahmed Sheriff; Georg Schett; Martin Herrmann; Peter Kern
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

4.  The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.

Authors:  Gabor Koncz; Anne-Odile Hueber
Journal:  Front Immunol       Date:  2012-07-25       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.